Needle-free Injection Systems Market by Product (Fillable and Prefilled), Source of Power (Spring-based Injector Systems and Gas Propelled/Air Forced Injector Systems), Type (Liquid-based, Projectile/Depot-based, and Powder-based), Usability (Disposable and Reusable), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, and Pain Management), and End User (Hospitals & Clinics, Home Care Settings, and Research Laboratories) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Needle-free injectors are used to administer drugs and vaccines into patients without pricking the skin as done in case of conventional needles. The global needle-free injection system market was valued at $8,166 million in 2016, and is estimated to reach $23,116 million by 2023, growing at a CAGR of 16.0% from 2017 to 2023. The market is expected to witness significant growth during the forecast period owing to improved immunization coverage, increase in demand for self-injection devices, prevalence of chronic diseases, incidence of communicable diseases due to needle stick injuries, and reduction in healthcare costs. However, dearth of trained personnel and limitation in usage for intravenous administration restrict the market growth.
The global needle-free injection system market is segmented on the basis of product, source of power, type, usability, site of delivery, application, end user, and region. Based on product, it is bifurcated into fillable and prefilled needle-free injection systems. Based on source of power, it is divided into spring-based and gas-propelled/air forced injector systems. According to type, the market is categorized into liquid-based, projectile/depot-based, and powder-based. On the basis of usability, it is divided into disposable and reusable needle-free injectors.
On the basis of site of delivery, the market is segmented into subcutaneous, intramuscular, and intradermal injectors. Based on application, it is divided into vaccine delivery, insulin delivery, pain management, and others. According to the end user, it is classified into hospitals & clinics, home care settings, research laboratories, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The global needle-free injection system market is highly competitive and is lucrative in nature. The key market players have adopted various developmental strategies such as product launch & approval, strategic acquisitions, and mergers to strengthen their market position.
Key Benefits for Stakeholders
By Product
The global needle-free injection system market is segmented on the basis of product, source of power, type, usability, site of delivery, application, end user, and region. Based on product, it is bifurcated into fillable and prefilled needle-free injection systems. Based on source of power, it is divided into spring-based and gas-propelled/air forced injector systems. According to type, the market is categorized into liquid-based, projectile/depot-based, and powder-based. On the basis of usability, it is divided into disposable and reusable needle-free injectors.
On the basis of site of delivery, the market is segmented into subcutaneous, intramuscular, and intradermal injectors. Based on application, it is divided into vaccine delivery, insulin delivery, pain management, and others. According to the end user, it is classified into hospitals & clinics, home care settings, research laboratories, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The global needle-free injection system market is highly competitive and is lucrative in nature. The key market players have adopted various developmental strategies such as product launch & approval, strategic acquisitions, and mergers to strengthen their market position.
Key Benefits for Stakeholders
- The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors.
- It offers an extensive analysis of the current and emerging market trends and dynamics through 2016–2023 to identify the upcoming market opportunities.
- Recent industry trends and developments and the future opportunities are also covered.
- Extensive knowledge about the key market players and their strategies is provided.
- Comprehensive analysis of factors that drive and restrain the growth of the market is provided.
By Product
- Fillable
- Prefilled
- Spring-based Injectors Systems
- Gas Propelled/Air Forced Injectors Systems
- Liquid-based
- Projectile/Depot-based
- Powder-based
- Disposable
- Reusable
- Subcutaneous Injectors
- Intramuscular Injectors
- Intradermal Injectors
- Vaccine Delivery
- Insulin Delivery
- Pain Management
- Others
- Hospitals & Clinics
- Home Care Settings
- Research Laboratories
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- The key players operating in this market include the following:
- Antares Pharma, Inc.
- Endo International plc
- PenJet Corporation
- Crossject Needle-Free Injection Systems
- PharmaJet
- Medical International Technology, Inc.
- INJEX Pharma AG
- National Medical Products Inc.
- Valeritas, Inc.
- European Pharma Group
CHAPTER 1 INTRODUCTION
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top wining strategies
3.2.1.1. Competitive intelligence of companies and their strategies
3.2.2. Top investment pockets
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Improved Immunization Coverage
3.3.1.2. Eliminate Risks of Needles
3.3.1.3. Reduce Health Care Costs
3.3.1.4. Increasing patient power
3.3.2. Restrains
3.3.2.1. Dearth of trained personnel
3.3.2.2. Limitation in intravenous administration
3.3.3. Opportunities
3.3.3.1. Wider range of applications
3.3.3.2. Technological advancements
3.3.4. Impact analysis
3.4. MARKET SHARE ANALYSIS, 2016
3.5. GOVERNMENT REGULATIONS
3.6. CLINICAL TRIALS
CHAPTER 4 NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. FILLABLE NEEDLE-FREE INJECTORS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. PREFILLED NEEDLE-FREE INJECTORS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 NEEDLE-FREE INJECTION SYSTEM MARKET, BY SOURCE OF POWER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. SPRING-BASED NEEDLE-FREE INJECTORS
5.2.1. Market size and forecast
5.3. GAS PROPELLED/ AIR FORCED INJECTOR SYSTEMS
5.3.1. Market size and forecast
CHAPTER 6 NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. LIQUID-BASED NEEDLE FREE INJECTORS
6.2.1. Market size and Forecast
6.3. PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTORS
6.3.1. Market size and forecast
6.4. POWDER-BASED NEEDLE FREE INJECTORS
6.4.1. Market size and forecast
CHAPTER 7 NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. SUBCUTANEOUS INJECTORS
7.2.1. Market size and forecast
7.3. INTRAMUSCULAR INJECTORS
7.3.1. Market size and forecast
7.4. INTRADERMAL INJECTORS
7.4.1. Market size and forecast
CHAPTER 8 NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. DISPOSABLE NEEDLE-FREE INJECTORS
8.2.1. Market size and forecast
8.3. REUSABLE NEEDLE-FREE INJECTORS
8.3.1. Market size and forecast
CHAPTER 9 NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION
9.1. OVERVIEW
9.1.1. Market size and forecast
9.2. VACCINE DELIVERY
9.2.1. Market size and forecast
9.3. INSULIN DELIVERY
9.3.1. Market size and forecast
9.4. PAIN MANAGEMENT
9.4.1. Main size and forecast
9.5. OTHER APPLICATIONS
9.5.1. Market size and forecast
CHAPTER 10 NEEDLE-FREE INJECTION SYSTEM MARKET, BY END-USER
10.1. OVERVIEW
10.1.1. Market size and forecast
10.2. HOSPITALS AND CLINICS
10.2.1. Market size and forecast
10.3. HOME CARE SETTINGS
10.3.1. Market size and forecast
10.4. RESEARCH LABORATORIES
10.4.1. Market size and forecast
10.5. OTHER END USERS
10.5.1. Market size and forecast
CHAPTER 11 NEEDLE-FREE INJECTION SYSTEM MARKET, BY REGION
11.1. OVERVIEW
11.1.1. Market size and forecast
11.2. NORTH AMERICA
11.2.1. Key market trends
11.2.2. Growth factors and opportunities
11.2.3. Market size and forecast
11.2.3.1. U.S. market size and forecast
11.2.3.2. Canada market size and forecast
11.2.3.3. Mexico market size and forecast
11.3. EUROPE
11.3.1. Key market trends
11.3.2. Growth factors and opportunities
11.3.3. Market size and forecast
11.3.3.1. Germany market size and forecast
11.3.3.2. France market size and forecast
11.3.3.3. UK market size and forecast
11.3.3.4. Italy market size and forecast
11.3.3.5. Spain market size and forecast
11.3.3.6. Rest of Europe market size and forecast
11.4. ASIA-PACIFIC
11.4.1. Key market trends
11.4.2. Growth factors and opportunities
11.4.3. Market size and forecast
11.4.3.1. Japan market size and forecast
11.4.3.2. China market size and forecast
11.4.3.3. India market size and forecast
11.4.3.4. Australia market size and forecast
11.4.3.5. Rest of Asia-Pacific market size and forecast
11.5. LAMEA
11.5.1. Key market trends
11.5.2. Growth factors and opportunities
11.5.3. Market size and forecast
11.5.3.1. Brazil market size and forecast
11.5.3.2. South Africa market size and forecast
11.5.3.3. Saudi Arabia market size and forecast
11.5.3.4. Rest of LAMEA market size and forecast
CHAPTER 12 COMPANY PROFILES
12.1. ANTARES PHARMA, INC.
12.1.1. Company overview
12.1.2. Operating business segments
12.1.3. Business performance
12.1.4. Key strategic moves and developments
12.2. MEDICAL INTERNATIONAL TECHNOLOGY, INC.
12.2.1. Company overview
12.2.2. Operating business segments
12.2.3. Business performance
12.2.4. Key strategic moves and developments
12.3. INJEX PHARMA AG
12.3.1. Company overview
12.3.2. Operating business segments
12.3.3. Business performance
12.3.4. Key strategic moves and developments
12.4. NATIONAL MEDICAL PRODUCTS INC.
12.4.1. Company overview
12.4.2. Operating business segments
12.4.3. Business performance
12.4.4. Key strategic moves and developments
12.5. EUROPEAN PHARMA GROUP
12.5.1. Company overview
12.5.2. Operating business segments
12.5.3. Business performance
12.5.4. Key strategic moves and developments
12.6. VALERITAS, INC.
12.6.1. Company overview
12.6.2. Operating business segments
12.6.3. Business performance
12.6.4. Key strategic moves and developments
12.7. PHARMAJET
12.7.1. Company overview
12.7.2. Operating business segments
12.7.3. Business performance
12.7.4. Key strategic moves and developments
12.8. PENJET CORPORATION
12.8.1. Company overview
12.8.2. Operating business segments
12.8.3. Business performance
12.8.4. Key strategic moves and developments
12.9. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS
12.9.1. Company overview
12.9.2. Operating business segments
12.9.3. Business performance
12.9.4. Key strategic moves and developments
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top wining strategies
3.2.1.1. Competitive intelligence of companies and their strategies
3.2.2. Top investment pockets
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Improved Immunization Coverage
3.3.1.2. Eliminate Risks of Needles
3.3.1.3. Reduce Health Care Costs
3.3.1.4. Increasing patient power
3.3.2. Restrains
3.3.2.1. Dearth of trained personnel
3.3.2.2. Limitation in intravenous administration
3.3.3. Opportunities
3.3.3.1. Wider range of applications
3.3.3.2. Technological advancements
3.3.4. Impact analysis
3.4. MARKET SHARE ANALYSIS, 2016
3.5. GOVERNMENT REGULATIONS
3.6. CLINICAL TRIALS
CHAPTER 4 NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. FILLABLE NEEDLE-FREE INJECTORS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. PREFILLED NEEDLE-FREE INJECTORS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 NEEDLE-FREE INJECTION SYSTEM MARKET, BY SOURCE OF POWER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. SPRING-BASED NEEDLE-FREE INJECTORS
5.2.1. Market size and forecast
5.3. GAS PROPELLED/ AIR FORCED INJECTOR SYSTEMS
5.3.1. Market size and forecast
CHAPTER 6 NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. LIQUID-BASED NEEDLE FREE INJECTORS
6.2.1. Market size and Forecast
6.3. PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTORS
6.3.1. Market size and forecast
6.4. POWDER-BASED NEEDLE FREE INJECTORS
6.4.1. Market size and forecast
CHAPTER 7 NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. SUBCUTANEOUS INJECTORS
7.2.1. Market size and forecast
7.3. INTRAMUSCULAR INJECTORS
7.3.1. Market size and forecast
7.4. INTRADERMAL INJECTORS
7.4.1. Market size and forecast
CHAPTER 8 NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. DISPOSABLE NEEDLE-FREE INJECTORS
8.2.1. Market size and forecast
8.3. REUSABLE NEEDLE-FREE INJECTORS
8.3.1. Market size and forecast
CHAPTER 9 NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION
9.1. OVERVIEW
9.1.1. Market size and forecast
9.2. VACCINE DELIVERY
9.2.1. Market size and forecast
9.3. INSULIN DELIVERY
9.3.1. Market size and forecast
9.4. PAIN MANAGEMENT
9.4.1. Main size and forecast
9.5. OTHER APPLICATIONS
9.5.1. Market size and forecast
CHAPTER 10 NEEDLE-FREE INJECTION SYSTEM MARKET, BY END-USER
10.1. OVERVIEW
10.1.1. Market size and forecast
10.2. HOSPITALS AND CLINICS
10.2.1. Market size and forecast
10.3. HOME CARE SETTINGS
10.3.1. Market size and forecast
10.4. RESEARCH LABORATORIES
10.4.1. Market size and forecast
10.5. OTHER END USERS
10.5.1. Market size and forecast
CHAPTER 11 NEEDLE-FREE INJECTION SYSTEM MARKET, BY REGION
11.1. OVERVIEW
11.1.1. Market size and forecast
11.2. NORTH AMERICA
11.2.1. Key market trends
11.2.2. Growth factors and opportunities
11.2.3. Market size and forecast
11.2.3.1. U.S. market size and forecast
11.2.3.2. Canada market size and forecast
11.2.3.3. Mexico market size and forecast
11.3. EUROPE
11.3.1. Key market trends
11.3.2. Growth factors and opportunities
11.3.3. Market size and forecast
11.3.3.1. Germany market size and forecast
11.3.3.2. France market size and forecast
11.3.3.3. UK market size and forecast
11.3.3.4. Italy market size and forecast
11.3.3.5. Spain market size and forecast
11.3.3.6. Rest of Europe market size and forecast
11.4. ASIA-PACIFIC
11.4.1. Key market trends
11.4.2. Growth factors and opportunities
11.4.3. Market size and forecast
11.4.3.1. Japan market size and forecast
11.4.3.2. China market size and forecast
11.4.3.3. India market size and forecast
11.4.3.4. Australia market size and forecast
11.4.3.5. Rest of Asia-Pacific market size and forecast
11.5. LAMEA
11.5.1. Key market trends
11.5.2. Growth factors and opportunities
11.5.3. Market size and forecast
11.5.3.1. Brazil market size and forecast
11.5.3.2. South Africa market size and forecast
11.5.3.3. Saudi Arabia market size and forecast
11.5.3.4. Rest of LAMEA market size and forecast
CHAPTER 12 COMPANY PROFILES
12.1. ANTARES PHARMA, INC.
12.1.1. Company overview
12.1.2. Operating business segments
12.1.3. Business performance
12.1.4. Key strategic moves and developments
12.2. MEDICAL INTERNATIONAL TECHNOLOGY, INC.
12.2.1. Company overview
12.2.2. Operating business segments
12.2.3. Business performance
12.2.4. Key strategic moves and developments
12.3. INJEX PHARMA AG
12.3.1. Company overview
12.3.2. Operating business segments
12.3.3. Business performance
12.3.4. Key strategic moves and developments
12.4. NATIONAL MEDICAL PRODUCTS INC.
12.4.1. Company overview
12.4.2. Operating business segments
12.4.3. Business performance
12.4.4. Key strategic moves and developments
12.5. EUROPEAN PHARMA GROUP
12.5.1. Company overview
12.5.2. Operating business segments
12.5.3. Business performance
12.5.4. Key strategic moves and developments
12.6. VALERITAS, INC.
12.6.1. Company overview
12.6.2. Operating business segments
12.6.3. Business performance
12.6.4. Key strategic moves and developments
12.7. PHARMAJET
12.7.1. Company overview
12.7.2. Operating business segments
12.7.3. Business performance
12.7.4. Key strategic moves and developments
12.8. PENJET CORPORATION
12.8.1. Company overview
12.8.2. Operating business segments
12.8.3. Business performance
12.8.4. Key strategic moves and developments
12.9. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS
12.9.1. Company overview
12.9.2. Operating business segments
12.9.3. Business performance
12.9.4. Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 2. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR FILLABLE NEEDLE-FREE INJECTOR SYSTEM, BY REGION, 2016-2023 ($MILLION)
TABLE 3. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR PREFILLED NEEDLE-FREE INJECTORS SYSTEM, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
TABLE 5. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR SPRING-BASED INJECTOR SYSTEMS, BY REGION, 2016-2023 ($MILLION)
TABLE 6. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR GAS PROPELLED/AIR FORCED INJECTOR SYSTEMS, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 8. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR LIQUID-BASED NEEDLE-FREE INJECTORS SYSTEMS, BY REGION, 2016-2023 ($MILLION)
TABLE 9. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTORS, BY REGION, 2016-2023 ($MILLION)
TABLE 10. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR POWDER-BASED NEEDLE FREE INJECTORS, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2016-2023 ($MILLION)
TABLE 12. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR SUBCUTANEOUS INJECTORS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR INTRAMUSCULAR INJECTORS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR INTRADERMAL INJECTORS, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 16. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR DISPOSABLE NEEDLE-FREE INJECTORS, BY REGION, 2016-2023 ($MILLION)
TABLE 17. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR REUSABLE NEEDLE-FREE INJECTORS, BY REGION, 2016-2023 ($MILLION)
TABLE 18. GLOBAL NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 19. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR VACCINE DELIVERY, BY REGION, 2016-2023 ($MILLION)
TABLE 20. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR INSULIN DELIVERY, BY REGION, 2016-2023 ($MILLION)
TABLE 21. NEEDLE-FREE INJECTION MARKET SYSTEMS FOR PAIN MANAGEMENT, BY REGION, 2016-2023 ($MILLION)
TABLE 22. NEEDLE-FREE INJECTION MARKET SYSTEMS FOR OTHER APPLICATIONS, BY REGION, 2016-2023 ($MILLION)
TABLE 23. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 24. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 25. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR HOME CARE SETTINGS, BY REGION, 2016-2023 ($MILLION)
TABLE 26. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR RESEARCH LABORATORIES, BY REGION, 2016-2023 ($MILLION)
TABLE 27. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR OTHER END USERS, BY REGION, 2016-2023 ($MILLION)
TABLE 28. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 30. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 31. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 33. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 35. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 36. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 37. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 38. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 39. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
TABLE 40. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 41. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023 ($MILLION)
TABLE 42. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 43. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 44. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 45. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 46. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 47. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
TABLE 48. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 49. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023 ($MILLION)
TABLE 50. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 51. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 52. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 53. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 54. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 55. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
TABLE 56. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 57. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023 ($MILLION)
TABLE 58. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 59. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 60. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 61. ANTARES PHARMA, INC.: COMPANY SNAPSHOT
TABLE 62. PENJET CORPORATION: COMPANY SNAPSHOT
TABLE 63. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS: COMPANY SNAPSHOT
TABLE 64. PHARMAJET: COMPANY SNAPSHOT
TABLE 65. MEDICAL INTERNATIONAL TECHNOLOGY, INC.: COMPANY SNAPSHOT
TABLE 66. INJEX PHARMA AG: COMPANY SNAPSHOT
TABLE 67. NATIONAL MEDICAL PRODUCTS INC.: COMPANY SNAPSHOT
TABLE 68. VALERITAS, INC.: COMPANY SNAPSHOT
TABLE 69. EUROPEAN PHARMA GROUP: COMPANY SNAPSHOT
TABLE 1. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 2. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR FILLABLE NEEDLE-FREE INJECTOR SYSTEM, BY REGION, 2016-2023 ($MILLION)
TABLE 3. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR PREFILLED NEEDLE-FREE INJECTORS SYSTEM, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
TABLE 5. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR SPRING-BASED INJECTOR SYSTEMS, BY REGION, 2016-2023 ($MILLION)
TABLE 6. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR GAS PROPELLED/AIR FORCED INJECTOR SYSTEMS, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 8. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR LIQUID-BASED NEEDLE-FREE INJECTORS SYSTEMS, BY REGION, 2016-2023 ($MILLION)
TABLE 9. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTORS, BY REGION, 2016-2023 ($MILLION)
TABLE 10. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR POWDER-BASED NEEDLE FREE INJECTORS, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2016-2023 ($MILLION)
TABLE 12. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR SUBCUTANEOUS INJECTORS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR INTRAMUSCULAR INJECTORS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR INTRADERMAL INJECTORS, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 16. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR DISPOSABLE NEEDLE-FREE INJECTORS, BY REGION, 2016-2023 ($MILLION)
TABLE 17. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR REUSABLE NEEDLE-FREE INJECTORS, BY REGION, 2016-2023 ($MILLION)
TABLE 18. GLOBAL NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 19. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR VACCINE DELIVERY, BY REGION, 2016-2023 ($MILLION)
TABLE 20. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR INSULIN DELIVERY, BY REGION, 2016-2023 ($MILLION)
TABLE 21. NEEDLE-FREE INJECTION MARKET SYSTEMS FOR PAIN MANAGEMENT, BY REGION, 2016-2023 ($MILLION)
TABLE 22. NEEDLE-FREE INJECTION MARKET SYSTEMS FOR OTHER APPLICATIONS, BY REGION, 2016-2023 ($MILLION)
TABLE 23. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 24. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 25. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR HOME CARE SETTINGS, BY REGION, 2016-2023 ($MILLION)
TABLE 26. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR RESEARCH LABORATORIES, BY REGION, 2016-2023 ($MILLION)
TABLE 27. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR OTHER END USERS, BY REGION, 2016-2023 ($MILLION)
TABLE 28. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 30. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 31. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 33. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 35. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 36. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 37. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 38. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 39. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
TABLE 40. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 41. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023 ($MILLION)
TABLE 42. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 43. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 44. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 45. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 46. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 47. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
TABLE 48. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 49. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023 ($MILLION)
TABLE 50. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 51. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 52. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 53. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 54. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 55. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
TABLE 56. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 57. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023 ($MILLION)
TABLE 58. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 59. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 60. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 61. ANTARES PHARMA, INC.: COMPANY SNAPSHOT
TABLE 62. PENJET CORPORATION: COMPANY SNAPSHOT
TABLE 63. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS: COMPANY SNAPSHOT
TABLE 64. PHARMAJET: COMPANY SNAPSHOT
TABLE 65. MEDICAL INTERNATIONAL TECHNOLOGY, INC.: COMPANY SNAPSHOT
TABLE 66. INJEX PHARMA AG: COMPANY SNAPSHOT
TABLE 67. NATIONAL MEDICAL PRODUCTS INC.: COMPANY SNAPSHOT
TABLE 68. VALERITAS, INC.: COMPANY SNAPSHOT
TABLE 69. EUROPEAN PHARMA GROUP: COMPANY SNAPSHOT
LIST OF FIGURES
FIGURE 1. MARKET SEGMENTATION
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2016)
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. TOP INVESTMENT POCKETS
FIGURE 9. CAUSES OF NEEDLE STICK INJURIES, TANZANIA, 2015
FIGURE 10. IMPACT ANALYSIS, 2016
FIGURE 11. MARKET SHARE ANALYSIS, 2016
FIGURE 12. U.S. MARKET SIZE AND FORECAST
FIGURE 13. CANADA MARKET SIZE AND FORECAST
FIGURE 14. MEXICO MARKET SIZE AND FORECAST
FIGURE 15. GERMANY MARKET SIZE AND FORECAST
FIGURE 16. FRANCE MARKET SIZE AND FORECAST
FIGURE 17. UK MARKET SIZE AND FORECAST
FIGURE 18. ITALY MARKET SIZE AND FORECAST
FIGURE 19. SPAIN MARKET SIZE AND FORECAST
FIGURE 20. REST OF EUROPE MARKET SIZE AND FORECAST
FIGURE 21. JAPAN MARKET SIZE AND FORECAST
FIGURE 22. CHINA MARKET SIZE AND FORECAST
FIGURE 23. INDIA MARKET SIZE AND FORECAST
FIGURE 24. AUSTRALIA MARKET SIZE AND FORECAST
FIGURE 25. REST OF ASIA-PACIFIC MARKET SIZE AND FORECAST
FIGURE 26. BRAZIL MARKET SIZE AND FORECAST
FIGURE 27. SOUTH AFRICA MARKET SIZE AND FORECAST
FIGURE 28. SAUDI ARABIA MARKET SIZE AND FORECAST
FIGURE 29. REST OF LAMEA MARKET SIZE AND FORECAST
FIGURE 1. MARKET SEGMENTATION
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2016)
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. TOP INVESTMENT POCKETS
FIGURE 9. CAUSES OF NEEDLE STICK INJURIES, TANZANIA, 2015
FIGURE 10. IMPACT ANALYSIS, 2016
FIGURE 11. MARKET SHARE ANALYSIS, 2016
FIGURE 12. U.S. MARKET SIZE AND FORECAST
FIGURE 13. CANADA MARKET SIZE AND FORECAST
FIGURE 14. MEXICO MARKET SIZE AND FORECAST
FIGURE 15. GERMANY MARKET SIZE AND FORECAST
FIGURE 16. FRANCE MARKET SIZE AND FORECAST
FIGURE 17. UK MARKET SIZE AND FORECAST
FIGURE 18. ITALY MARKET SIZE AND FORECAST
FIGURE 19. SPAIN MARKET SIZE AND FORECAST
FIGURE 20. REST OF EUROPE MARKET SIZE AND FORECAST
FIGURE 21. JAPAN MARKET SIZE AND FORECAST
FIGURE 22. CHINA MARKET SIZE AND FORECAST
FIGURE 23. INDIA MARKET SIZE AND FORECAST
FIGURE 24. AUSTRALIA MARKET SIZE AND FORECAST
FIGURE 25. REST OF ASIA-PACIFIC MARKET SIZE AND FORECAST
FIGURE 26. BRAZIL MARKET SIZE AND FORECAST
FIGURE 27. SOUTH AFRICA MARKET SIZE AND FORECAST
FIGURE 28. SAUDI ARABIA MARKET SIZE AND FORECAST
FIGURE 29. REST OF LAMEA MARKET SIZE AND FORECAST
